Page 73 - Mployee Wellness Programs News Today

Hospital M&A activity has been returning to pre-pandemic levels this year, according to a new report. There were 18 M&A transactions in Q3, compared to seven in Q3 2021 and 10 in Q3 of last year. The reason why M&A activity is regaining its momentum is because hospitals are seeking partnerships to grow and protect their long-term financial sustainability — the report found financial distress was the driving factor behind nearly 40% of deals announced during Q3.

The last few years, both during and after the pandemic, have been turbulent times for healthcare providers and patients alike. For now, although it appears that healthcare staffing shortages will continue, providers are not without practical strategies for attracting and retaining talent.

A recent webinar sponsored by AVIA Health and Seamless MD examined how health systems use remote patient monitoring beyond the usual chronic condition applications, including surgical prep and recovery, women's health, and more.

Health tech to support care for seniors and track the progression of conditions such as Parkinson's disease and heart failure were on display at HLTH 2023. The National Institute on Aging also added a startup boot camp leading up to HLTH.

At HLTH 2023, I had dozens of conversations with providers, digital health investors, startup CEOs and other players in the healthcare industry. When I got home, I compiled seven refreshingly honest takes I heard from them while at the conference.

At the HLTH conference last week, MedCity News' editorial team interviewed 11 health leaders from a variety of organizations to get a sense of which areas within healthcare will see consolidation over the next 12 months.

If you could only do one thing to improve the health of children in the U.S., it would have to be in the behavioral health sphere, Nemours Children's Health CEO Lawrence Moss declared at HLTH. The state of youth mental health has reached a crisis point in the U.S., and Moss' health system is working hard to address this. Some of its efforts include embedding behavioral health into primary care and deploying behavioral health workers in schools.

Pfizer’s new FDA-approved ulcerative colitis drug Velsipity comes from its $6.7 billion Arena Pharmaceuticals acquisition. The small molecule will compete against blockbuster Bristol Myers Squibb drug Zeposia, which addresses the same target.

At HLTH, General Catalyst Principal Candace Richardson discussed some of the questions she frequently asks startups during investment meetings. Some of these include "Do you stratify your outcomes data by different populations to ensure your model works well for everyone?" and "Is serving Medicaid populations on your roadmap?"

Cancer and pharmacy services are driving up costs for employers. One Mercer exec recently laid out several recommendations for employers to manage these costs.